Funding for this research was provided by:
Jimma University (Clipharm03)
Received: 6 August 2019
Accepted: 3 January 2020
First Online: 13 January 2020
Ethics approval and consent to participate
: Ethical clearance and approval of the study were obtained from Jimma University, Institute of Health ethical review board before starting the actual data collection. Subsequent permission was granted from Jimma University Medical Center to access medical records. Participation of patients in this study was entirely voluntary. Confidentiality of the collected data was ensured through anonymity. Each participant was asked to sign a written informed consent before data collection. The right of participants to withdraw from the interview or not to participate was respected. Patient’s privacy kept while interviewing.
: Not applicable.
: There are no competing interests to declare.